With an experienced team comprised of around 200 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. * Proactively originate early stage partnering opportunities for new portfolio additions like co-development agreements, based on a deep understanding of global market dynamics * Senior‑level experience in licensing, business development, and alliance management within generic or biotech companies, ideally with biosimilars focus * Individual development and career paths, internal trainings and participation in international conferences and scientific events
mehr